Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Asymptomatic or Minimally Symptomatic”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Large-scale testing (Phase 3)Study completedNCT01057810
What this trial is testing

Phase 3 Study of Immunotherapy to Treat Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 837
Early research (Phase 1)Study completedNCT03024216
What this trial is testing

Clinical Study of Atezolizumab (Anti-PD-L1) and Sipuleucel-T in Patients With Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
University of Hawaii 37
Testing effectiveness (Phase 2)Study completedNCT02463799
What this trial is testing

Study of Sipuleucel-T W/ or W/O Radium-223 in Men With Asymptomatic or Minimally Symptomatic Bone-MCRPC

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 36
Testing effectiveness (Phase 2)Study completedNCT01521949
What this trial is testing

Study of Acai Juice in Asymptomatic or Minimally Symptomatic Prostate Cancer Patients With Rising PSA

Who this might be right for
Prostate Cancer
University of Colorado, Denver 21
Testing effectiveness (Phase 2)Ended earlyNCT01817738
What this trial is testing

Trial of RNActive®-Derived Prostate Cancer Vaccine in Metastatic Castrate-refractory Prostate Cancer

Who this might be right for
Prostate Cancer
CureVac 197
Large-scale testing (Phase 3)Study completedNCT01322490
What this trial is testing

A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer Metastatic
Bavarian Nordic 1,297
Testing effectiveness (Phase 2)Study completedNCT01519414
What this trial is testing

Tivantinib in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Hormone-Resistant Prostate CancerProstate AdenocarcinomaRecurrent Prostate Carcinoma+1 more
National Cancer Institute (NCI) 78
Not applicableStudy completedNCT00263250
What this trial is testing

Watchful Waiting Versus Open Tension-free Repair of Inguinal Hernia in Asymptomatic or Minimally Symptomatic Men

Who this might be right for
Inguinal Hernia
Creighton University 724
Testing effectiveness (Phase 2)Looking for participantsNCT05987644
What this trial is testing

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

Who this might be right for
Lung CancerNSCLCBrain Metastases
Joshua Palmer 56
Testing effectiveness (Phase 2)Study completedNCT02279862
What this trial is testing

Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive

Who this might be right for
Prostate Cancer
Bristol-Myers Squibb 82
Testing effectiveness (Phase 2)Study completedNCT03523351
What this trial is testing

Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain

Who this might be right for
Metastatic Solid Tumors of Metastatic Disease
Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Study completedNCT01560923
What this trial is testing

Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Masonic Cancer Center, University of Minnesota 47
Testing effectiveness (Phase 2)Study completedNCT01881867
What this trial is testing

CYT107 After Vaccine Treatment (Provenge®) in Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+1 more
Fred Hutchinson Cancer Center 54
Not applicableLooking for participantsNCT07146074
What this trial is testing

Early Radiotherapy Versus Observation for High-risk Asymptomatic or Minimally Symptomatic Bone Metastases

Who this might be right for
Solid NeoplasmsBone MetastasesAsymptomatic or Minimally Symptomatic+1 more
Cancer Research Antwerp 120